| Basics |
Bristol-Myers Squibb Co.
Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceuticals products. The company operates in one segment that is Biopharmaceuticals.
|
| IPO Date: |
December 31, 1981 |
| Sector: |
Healthcare |
| Industry: |
Pharma |
| Market Cap: |
$99.29B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.41 | 0.92%
|
| Avg Daily Range (30 D): |
$0.60 | 1.27%
|
| Avg Daily Range (90 D): |
$0.75 | 1.39%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
9.37M |
| Avg Daily Volume (30 D): |
12.28M |
| Avg Daily Volume (90 D): |
11.06M |
| Trade Size |
| Avg Trade Size (Sh.): |
183 |
| Avg Trade Size (Sh.) (30 D): |
107 |
| Avg Trade Size (Sh.) (90 D): |
97 |
| Institutional Trades |
| Total Inst.Trades: |
122,902 |
| Avg Inst. Trade: |
$4.93M |
| Avg Inst. Trade (30 D): |
$5.79M |
| Avg Inst. Trade (90 D): |
$6.11M |
| Avg Inst. Trade Volume: |
.11M |
| Avg Inst. Trades (Per Day): |
22 |
| Market Closing Trades |
| Avg Closing Trade: |
$57.68M |
| Avg Closing Trade (30 D): |
$116.52M |
| Avg Closing Trade (90 D): |
$120.31M |
| Avg Closing Volume: |
1.07M |
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
$2.69
|
$1.21
|
$.04
|
|
Diluted EPS
|
$2.68
|
$1.2
|
$.04
|
|
Revenue
|
$ 47.64B
|
$ 11.2B
|
$ 12.34B
|
|
Gross Profit
|
$ 33.57B
|
$ 8.17B
|
$ 7.53B
|
|
Net Income / Loss
|
$ 5.44B
|
$ 2.46B
|
$ 76M
|
|
Operating Income / Loss
|
$ 6.11B
|
$ 2.97B
|
$ 175M
|
|
Cost of Revenue
|
$ 14.07B
|
$ 3.03B
|
$ 4.81B
|
|
Net Cash Flow
|
$ 1.54B
|
$ 528M
|
$ 2.45B
|
|
PE Ratio
|
18.19
|
|
|
|
|
|
